Quick Takeaways
- Braden M. Leonard has 14 issuer positions tracked on this page.
- Estimated disclosed ownership value: $511,226,842.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Braden M. Leonard
- Location
- Zionsville, IN
- Summary
- The estimated net worth of Braden M. Leonard is at least $511,226,842 dollars as of 12 May 2026. Braden M. Leonard is the 10%+ Owner of Gemini Therapeutics, Inc. /DE and owns shares of Disc Medicine, Inc. (IRON) stock worth about $354.99M. Braden M. Leonard is the 10%+ Owner of Aclaris Therapeutics, Inc. and owns shares of Aclaris Therapeutics, Inc. (ACRS) stock worth about $80.92M. Braden M. Leonard is the 10%+ Owner of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $30.24M. Braden M. Leonard is the 10%+ Owner of Cyteir Therapeutics, Inc. and owns shares of Cyteir Therapeutics, Inc. stock worth about $11.77M. Braden M. Leonard is the 10%+ Owner of Adverum Biotechnologies, Inc. and owns shares of Adverum Biotechnologies, Inc. stock worth about $9.03M. Braden M. Leonard is the 10%+ Owner of Outset Medical, Inc. and owns shares of Outset Medical, Inc. (OM) stock worth about $8.88M. Braden M. Leonard is the 10%+ Owner of Satsuma Pharmaceuticals, Inc. and owns shares of Satsuma Pharmaceuticals, Inc. stock worth about $6M. Braden M. Leonard is the 10%+ Owner of AN2 Therapeutics, Inc. and owns shares of AN2 Therapeutics, Inc. (ANTX) stock worth about $3.29M. Braden M. Leonard is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $3.18M. Braden M. Leonard is the 10%+ Owner of RETRACTABLE TECHNOLOGIES INC and owns shares of RETRACTABLE TECHNOLOGIES INC (RVP) stock worth about $1.32M. Braden M. Leonard is the Former 10% owner of RPHM of Reneo Pharmaceuticals, Inc. and owns shares of OnKure Therapeutics, Inc. (OKUR) stock worth about $670.1K. Braden M. Leonard is the Former 10% owner of AVROBIO of Tectonic Therapeutic, Inc. and owns shares of Tectonic Therapeutic, Inc. (TECX) stock worth about $563.8K. Braden M. Leonard is the 10%+ Owner of Talis Biomedical Corp and owns shares of Talis Biomedical Corp stock worth about $369.1K.
- Signature
- Braden M Leonard
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Braden M. Leonard and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Gemini Therapeutics, Inc. /DE ($354,993,375).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Braden M. Leonard
IRON
Forms 3/4/5
Gemini Therapeutics, Inc. /DE
- Relationship
- 10%+ Owner
- Holdings value
- $354,993,375
- Past year net change
- Change %
- Report period
- 26 Oct 2022
ACRS
Forms 3/4/5
Aclaris Therapeutics, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $80,924,775
- Past year net change
- -$1,359,000
- Change %
- -1.7%
- Report period
- 27 Apr 2026
ELVN
Forms 3/4/5
IMARA Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $30,236,309
- Past year net change
- Change %
- Report period
- 03 Jan 2023
CYT
Forms 3/4/5
Cyteir Therapeutics, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $11,767,706
- Past year net change
- Change %
- Report period
- 20 Mar 2024
ADVM
Forms 3/4/5
Adverum Biotechnologies, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $9,030,626
- Past year net change
- -$4,608,205
- Change %
- -34%
- Report period
- 04 Dec 2025
OM
Forms 3/4/5
Outset Medical, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $8,884,131
- Past year net change
- Change %
- Report period
- 08 May 2026
STSA
Forms 3/4/5
Satsuma Pharmaceuticals, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $5,996,900
- Past year net change
- Change %
- Report period
- 21 Nov 2022
ANTX
Forms 3/4/5
AN2 Therapeutics, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $3,289,000
- Past year net change
- -$3,090,477
- Change %
- -48%
- Report period
- 12 Jun 2025
MTCR
Forms 3/4/5
Metacrine, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $3,177,468
- Past year net change
- Change %
- Report period
- 19 Dec 2022
RVP
Forms 3/4/5
RETRACTABLE TECHNOLOGIES INC
- Relationship
- 10%+ Owner
- Holdings value
- $1,323,572
- Past year net change
- Change %
- Report period
- 29 Dec 2022
OKUR
Forms 3/4/5
Reneo Pharmaceuticals, Inc.
- Relationship
- Former 10% owner of RPHM
- Holdings value
- $670,111
- Past year net change
- Change %
- Report period
- 07 Oct 2024
TECX
Forms 3/4/5
Tectonic Therapeutic, Inc.
- Relationship
- Former 10% owner of AVROBIO
- Holdings value
- $563,795
- Past year net change
- Change %
- Report period
- 20 Jun 2024
TLIS
Forms 3/4/5
Talis Biomedical Corp
- Relationship
- 10%+ Owner
- Holdings value
- $369,074
- Past year net change
- Change %
- Report period
- 05 Sep 2024
ASTC
Forms 3/4/5
ASTROTECH Corp
- Relationship
- 10%+ Owner
- Holdings value
- $0
- Past year net change
- -$1,625,071
- Change %
- -100%
- Report period
- 03 Oct 2025
Insider Transactions Reported by Braden M. Leonard:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.